Answer
Clopidogrel increases exposure to selexipag’s active metabolite approximately 2.2-fold after a 300 mg loading dose and 2.7-fold with a 75 mg once-daily maintenance dose.
Sources for this answer
- Uptravi 200 microgram film-coated tablets (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.5 Interaction with other medicinal products · Version 19Document updated
Sources checked